| KURA ONCOLOGY DL-,0001 |
| USA |
| Gesundheit |
| US50127T1097 / A143UH |
| KUR (Frankfurt) / KURA (NASDAQ) |
| FRA:KUR, ETR:KUR, KUR:GR, NASDAQ:KURA |
| - |
| https://kuraoncology.com/ |
|
Kura Oncology Inc. is a clinical-stage biopharmaceutical company focused on the research, development, and commercialization of precision medicines for cancer treatment. It specializes in novel therapies that selectively target cancer cells, addressi..
>Volltext.. |
| 891.91 Mio. EUR |
| 458.93 Mio. EUR |
| 66.12 Mio. EUR |
| -271.24 Mio. EUR |
| -254.09 Mio. EUR |
| -2.88 EUR |
| 20.94 Mio. EUR |
| 60.14 Mio. EUR |
| -95.68 Mio. EUR |
| 4.39 |
| -4.35% |
| -55.25% |
| - |
| - |
| - |
| KURA ONCOLOGY |
| 25.08.26 |